Dofetilide

Especificaciones

115256-11-6Número CAS

638-817-5Número CE

N-[4-[2-[2-[4-(methanesulfonamido)phenoxy]ethyl-methylamino]ethyl]phenyl]methanesulfonamideNombre IUPAC

C19H27N3O5S2Fórmula química

441.6 g/molPeso molecular

Dofetilide; 115256-11-6; Tikosyn; Dofetilida; Dofetilidum; UK-68,798; UK-68798; DTXSID5046433; R4Z9X1N2ND; beta-((p-Methanesulfonamidophenethyl)methylamino)methanesulfono-p-phenetidide; Methanesulfonamide, N-[4-[2-[methyl[2-[4-[(methylsulfonyl)amino]phenoxy]ethyl]amino]ethyl]phenyl]-; CHEBI:4681; DTXCID3026433; N-[4-[2-[Methyl[2-[4-[(methylsulfonyl)amino]phenoxy]ethyl]amino]ethyl]phenyl]methanesulfonamide; Methanesulfonamide, N-(4-(2-(methyl(2-(4-((methylsulfonyl)amino)phenoxy)ethyl)amino)ethyl)phenyl)-; 1-MSPMPE; N-[4-(2-{[2-(4-methanesulfonamidophenoxy)ethyl](methyl)amino}ethyl)phenyl]methanesulfonamide; N-(4-{2-[methyl(2-{4-[(methylsulfonyl)amino]phenoxy}ethyl)amino]ethyl}phenyl)methanesulfonamide; N-(4-(2-(2-(4-methanesulfonamidophenyl)ethyl-methylamino)ethoxy)phenyl)methanesulfonamide; N-[4-[2-[2-(4-methanesulfonamidophenyl)ethyl-methylamino]ethoxy]phenyl]methanesulfonamide; Dofetilide 0.5mg; N-(4-(2-((2-(4-methanesulfonamidophenoxy)ethyl)(methyl)amino)ethyl)phenyl)methanesulfonamide; N-(4-(2-(methyl(2-(4-((methylsulfonyl)amino)phenoxy)ethyl)amino)ethyl)phenyl)methanesulfonamide; DOFETILDE; 1-(4-methanesulfonamidophenoxy)-2-(N-(4-methanesulfonamidophenethyl)-N-methylamine)ethane; Dofetilide 0.25mg; Dofetilide 0.125mg; RefChem:57792; C01BD04; Dofetilidum [INN-Latin]; N-(4-(2-(methyl(2-(4-(methylsulfonamido)phenoxy)ethyl)amino)ethyl)phenyl)methanesulfonamide; Dofetilida [INN-Spanish]; UK 68798; MFCD00869707; C19H27N3O5S2; CHEMBL473; 1-(4-Methanesulphonamidophenoxy)-2-[N-(4-methanesulphonamidophenethyl)-N-methylamino]ethane; NCGC00164549-01; Dofetilide (>90%); N-[4-(2-{[2-(4-methanesulfonamidophenyl)ethyl](methyl)amino}ethoxy)phenyl]methanesulfonamide; N-[4-(2-{2-[4-(methanesulphonamido)phenoxyl]-N-methylethylamino}ethyl)phenyl]-methanesulphonamide; Xelide; SMR000466333; Tikosyn (TN); CAS-115256-11-6; UK 68,798; UNII-R4Z9X1N2ND; N-[4-[2-[2-[4-(methanesulfonamido)phenoxy]ethyl-methylamino]ethyl]phenyl]methanesulfonamide; HSDB 7927; N-[4-[2-[Methyl[2-[4-(methylsulfonamido)phenoxy]ethyl]amino]ethyl]phenyl]methanesulfonamide; IXTMWRCNAAVVAI-UHFFFAOYSA-N; Dofetilide [USAN:USP:INN:BAN]; Dofetilide (Tikosyn); UK68798; Dofetilide (Standard); Dofetilide (Tikosyn)?; DOFETILIDE [MI]; DOFETILIDE [INN]; DOFETILIDE [JAN]; DOFETILIDE [USAN]; DOFETILIDE [VANDF]; DOFETILIDE [MART.]; DOFETILIDE [USP-RS]; DOFETILIDE [WHO-DD]; SCHEMBL16135; Dofetilide (JAN/USP/INN); MLS000759442; MLS001424185; MLS006010154; DOFETILIDE [EMA EPAR]; Dofetilide - Bio-X trade mark; GTPL2604; orb1226902; orb1300735; DOFETILIDE [ORANGE BOOK]; Dofetilide, >=98% (HPLC); HY-B0232R; DOFETILIDE [USP MONOGRAPH]; GLXC-05217; HMS2051N14; HMS2089F03; HMS2232H19; HMS3261G03; HMS3370B18; HMS3393N14; HMS3655A17; HMS3715H20; HMS5079J08; HY-B0232; Tox21_112178; Tox21_500351; AC-385; BDBM50031720; EBC-11239; HB1078; NSC786034; s1658; AKOS005259921; Tox21_112178_1; CCG-101037; DB00204; FD09968; NC00287; NSC-786034; MRF-0000317; N-[4-[2-[2-[4-(methanesulfonamido)phenoxy]ethyl-methyl-amino]ethyl]phenyl]methanesulfonamide; NCGC00164549-02; NCGC00164549-10; NCGC00261036-01; BD164377; SY227006; DB-041252; NS00068338; SW197667-2; T6476; C07751; D00647; H11953; AB00639976-06; AB00639976-08; AB00639976_09; EN300-19768191; F819018; SR-01000759368; 11W-0619; Q3712521; SR-01000759368-4; BRD-K86887724-001-05-6; BRD-K86887724-001-09-8; BRD-K86887724-001-10-6; Dofetilide, United States Pharmacopeia (USP) Reference Standard; .BETA.-((P-METHANESULFONAMIDOPHENETHYL)METHYLAMINO)METHANESULFONO-P-PHENETIDIDE; 1-(4-Methansulphonamidophenoxy)-2-[N-(4-methanesulphonamidophenethyl)-N-methylamino]ethane; (Dofetilide) N-[4-(2-{[2-(4-Methanesulfonylamino-phenyl)-ethyl]-methylamino}-ethoxy)-phenyl]-methanesulfonamide; 1-(4-Methanesulphonamidophenoxy)-2-[N-(4-methanesulphonamidophenethyl)-N-methylamino] ethane; N-(4-{2-[{2-[4-(Methanesulfonamido)phenoxy]ethyl}(methyl)amino]ethyl}phenyl)methanesulfonamide; N-[4-(2-{[2-(4-methanesulfonylamino-phenoxy)-ethyl]-methyl-amino}-ethyl)-phenyl]-methanesulfonamide; N-[4-(2-{[2-(4-Methanesulfonylamino-phenyl)-ethyl]-methyl-amino}-ethoxy)-phenyl]-methanesulfonamide (dofetilide); N-[4-(2-{[2-(4-Methanesulfonylamino-phenyl)-ethyl]-methyl-amino}-ethoxy)-phenyl]-methanesulfonamide (UK-68798); N-[4-(2-{[2-(4-METHANESULFONYLAMINO-PHENYL)-ETHYL]-METHYL-AMINO}-ETHOXY)-PHENYL]-METHANESULFONAMIDE DOFETILIDE; N-[4-[2-[Methyl[2-[4-[(methylsulfonyl)amino]phenoxy]ethyl]amino]ethyl]phenyl]-methanesulfonamide; UK-68798; Tikosyn;Sinónimos